Global Lysozyme Antibody Market Growth 2025-2031

The global Lysozyme Antibody market size is predicted to grow from US$ 106 million in 2025 to US$ 145 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.

Lysozyme antibodies are a type of polyclonal antibody that can specifically bind to lysozyme protein and are mainly used for in vitro immunoassays to detect lysozyme. Lysozyme is a glucosidase in neutrophil granules and is present in the lacrimal glands, saliva, and nasal secretions. It has antibacterial activity and can protect the body from being destroyed by invading bacteria.

United States market for Lysozyme Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Lysozyme Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Lysozyme Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Lysozyme Antibody players cover Zeta Corporation, Invitrogen, Novus Biologicals, Bio SB, Bio-Techne, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Lysozyme Antibody Industry Forecast” looks at past sales and reviews total world Lysozyme Antibody sales in 2024, providing a comprehensive analysis by region and market sector of projected Lysozyme Antibody sales for 2025 through 2031. With Lysozyme Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lysozyme Antibody industry.

This Insight Report provides a comprehensive analysis of the global Lysozyme Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lysozyme Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lysozyme Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lysozyme Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lysozyme Antibody.

This report presents a comprehensive overview, market shares, and growth opportunities of Lysozyme Antibody market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Monoclonal Lysozyme Antibody
Polyclonal Lysozyme Antibody
Recombinant Monoclonal Lysozyme Antibody

Segmentation by Application:
Immunohistochemistry
Western Blot
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Zeta Corporation
Invitrogen
Novus Biologicals
Bio SB
Bio-Techne
Proteintech
Bio-Rad Antibodies
NeoBiotechnologies
Biopioneer
Beyotime

Key Questions Addressed in this Report

What is the 10-year outlook for the global Lysozyme Antibody market?

What factors are driving Lysozyme Antibody market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Lysozyme Antibody market opportunities vary by end market size?

How does Lysozyme Antibody break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.